USING PROTATRAN 4-CHLOR-2-METHYLPHENOXYACETATE (CHLORCRESACIN) FOR ARREST OF CHOLESTEROLESTERASE ACTIVITY

FIELD: medicine.SUBSTANCE: correcting pathological processes caused by high cholesterolesterase activity is ensured by using protatran 4-chlor-2-methylphenoxyacetate (chlorcresacin).EFFECT: using this compound enables increasing the cholesterol resistance of the vascular system involved into a devel...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: RASULOV MAKSUD MUKHAMEDZHANOVICH, SUSOVA MARIJA IGOREVNA, ABZAEVA KLAVDIJA ALSYKOVNA, VORONKOV MIKHAIL GRIGOR'EVICH, JAKHKIND MIKHAIL IL'ICH, RASULOV RIZO MAKSUDOVICH
Format: Patent
Sprache:eng ; rus
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator RASULOV MAKSUD MUKHAMEDZHANOVICH
SUSOVA MARIJA IGOREVNA
ABZAEVA KLAVDIJA ALSYKOVNA
VORONKOV MIKHAIL GRIGOR'EVICH
JAKHKIND MIKHAIL IL'ICH
RASULOV RIZO MAKSUDOVICH
description FIELD: medicine.SUBSTANCE: correcting pathological processes caused by high cholesterolesterase activity is ensured by using protatran 4-chlor-2-methylphenoxyacetate (chlorcresacin).EFFECT: using this compound enables increasing the cholesterol resistance of the vascular system involved into a developing atherosclerotic process.2 tbl Настоящее изобретение относится к медицине, а именно к терапии, и касается коррекции патологических процессов, обусловленных повышенной активностью холестеролэстеразы. Для этого применяют протатран 4-хлор-2-метилфеноксиацетат (хлоркрезацин). Применение этого соединения позволяет повышать устойчивость сосудистой системы к холестерину при развитии атеросклеротического процесса. 2 табл.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_RU2563831C1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>RU2563831C1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_RU2563831C13</originalsourceid><addsrcrecordid>eNqNijEKwkAQRdNYiHqHKbXYIomK7TBM3IW4K5OJmCoEWUEQDcT7Y5AcwOr9z3vz5FFXzh_hLEFRBT1sDdkyiMnMidU25dmyD9cGiceAYf2zJFwhOb-BIgigjFchFEA2lONkmYAVA5K6i9Nmmczu3XOIq4mLBApWsib27zYOfXeLr_hppc52-_yQp5TmfyRfKOU2Hg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>USING PROTATRAN 4-CHLOR-2-METHYLPHENOXYACETATE (CHLORCRESACIN) FOR ARREST OF CHOLESTEROLESTERASE ACTIVITY</title><source>esp@cenet</source><creator>RASULOV MAKSUD MUKHAMEDZHANOVICH ; SUSOVA MARIJA IGOREVNA ; ABZAEVA KLAVDIJA ALSYKOVNA ; VORONKOV MIKHAIL GRIGOR'EVICH ; JAKHKIND MIKHAIL IL'ICH ; RASULOV RIZO MAKSUDOVICH</creator><creatorcontrib>RASULOV MAKSUD MUKHAMEDZHANOVICH ; SUSOVA MARIJA IGOREVNA ; ABZAEVA KLAVDIJA ALSYKOVNA ; VORONKOV MIKHAIL GRIGOR'EVICH ; JAKHKIND MIKHAIL IL'ICH ; RASULOV RIZO MAKSUDOVICH</creatorcontrib><description>FIELD: medicine.SUBSTANCE: correcting pathological processes caused by high cholesterolesterase activity is ensured by using protatran 4-chlor-2-methylphenoxyacetate (chlorcresacin).EFFECT: using this compound enables increasing the cholesterol resistance of the vascular system involved into a developing atherosclerotic process.2 tbl Настоящее изобретение относится к медицине, а именно к терапии, и касается коррекции патологических процессов, обусловленных повышенной активностью холестеролэстеразы. Для этого применяют протатран 4-хлор-2-метилфеноксиацетат (хлоркрезацин). Применение этого соединения позволяет повышать устойчивость сосудистой системы к холестерину при развитии атеросклеротического процесса. 2 табл.</description><language>eng ; rus</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20150920&amp;DB=EPODOC&amp;CC=RU&amp;NR=2563831C1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20150920&amp;DB=EPODOC&amp;CC=RU&amp;NR=2563831C1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>RASULOV MAKSUD MUKHAMEDZHANOVICH</creatorcontrib><creatorcontrib>SUSOVA MARIJA IGOREVNA</creatorcontrib><creatorcontrib>ABZAEVA KLAVDIJA ALSYKOVNA</creatorcontrib><creatorcontrib>VORONKOV MIKHAIL GRIGOR'EVICH</creatorcontrib><creatorcontrib>JAKHKIND MIKHAIL IL'ICH</creatorcontrib><creatorcontrib>RASULOV RIZO MAKSUDOVICH</creatorcontrib><title>USING PROTATRAN 4-CHLOR-2-METHYLPHENOXYACETATE (CHLORCRESACIN) FOR ARREST OF CHOLESTEROLESTERASE ACTIVITY</title><description>FIELD: medicine.SUBSTANCE: correcting pathological processes caused by high cholesterolesterase activity is ensured by using protatran 4-chlor-2-methylphenoxyacetate (chlorcresacin).EFFECT: using this compound enables increasing the cholesterol resistance of the vascular system involved into a developing atherosclerotic process.2 tbl Настоящее изобретение относится к медицине, а именно к терапии, и касается коррекции патологических процессов, обусловленных повышенной активностью холестеролэстеразы. Для этого применяют протатран 4-хлор-2-метилфеноксиацетат (хлоркрезацин). Применение этого соединения позволяет повышать устойчивость сосудистой системы к холестерину при развитии атеросклеротического процесса. 2 табл.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNijEKwkAQRdNYiHqHKbXYIomK7TBM3IW4K5OJmCoEWUEQDcT7Y5AcwOr9z3vz5FFXzh_hLEFRBT1sDdkyiMnMidU25dmyD9cGiceAYf2zJFwhOb-BIgigjFchFEA2lONkmYAVA5K6i9Nmmczu3XOIq4mLBApWsib27zYOfXeLr_hppc52-_yQp5TmfyRfKOU2Hg</recordid><startdate>20150920</startdate><enddate>20150920</enddate><creator>RASULOV MAKSUD MUKHAMEDZHANOVICH</creator><creator>SUSOVA MARIJA IGOREVNA</creator><creator>ABZAEVA KLAVDIJA ALSYKOVNA</creator><creator>VORONKOV MIKHAIL GRIGOR'EVICH</creator><creator>JAKHKIND MIKHAIL IL'ICH</creator><creator>RASULOV RIZO MAKSUDOVICH</creator><scope>EVB</scope></search><sort><creationdate>20150920</creationdate><title>USING PROTATRAN 4-CHLOR-2-METHYLPHENOXYACETATE (CHLORCRESACIN) FOR ARREST OF CHOLESTEROLESTERASE ACTIVITY</title><author>RASULOV MAKSUD MUKHAMEDZHANOVICH ; SUSOVA MARIJA IGOREVNA ; ABZAEVA KLAVDIJA ALSYKOVNA ; VORONKOV MIKHAIL GRIGOR'EVICH ; JAKHKIND MIKHAIL IL'ICH ; RASULOV RIZO MAKSUDOVICH</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_RU2563831C13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; rus</language><creationdate>2015</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>RASULOV MAKSUD MUKHAMEDZHANOVICH</creatorcontrib><creatorcontrib>SUSOVA MARIJA IGOREVNA</creatorcontrib><creatorcontrib>ABZAEVA KLAVDIJA ALSYKOVNA</creatorcontrib><creatorcontrib>VORONKOV MIKHAIL GRIGOR'EVICH</creatorcontrib><creatorcontrib>JAKHKIND MIKHAIL IL'ICH</creatorcontrib><creatorcontrib>RASULOV RIZO MAKSUDOVICH</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>RASULOV MAKSUD MUKHAMEDZHANOVICH</au><au>SUSOVA MARIJA IGOREVNA</au><au>ABZAEVA KLAVDIJA ALSYKOVNA</au><au>VORONKOV MIKHAIL GRIGOR'EVICH</au><au>JAKHKIND MIKHAIL IL'ICH</au><au>RASULOV RIZO MAKSUDOVICH</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>USING PROTATRAN 4-CHLOR-2-METHYLPHENOXYACETATE (CHLORCRESACIN) FOR ARREST OF CHOLESTEROLESTERASE ACTIVITY</title><date>2015-09-20</date><risdate>2015</risdate><abstract>FIELD: medicine.SUBSTANCE: correcting pathological processes caused by high cholesterolesterase activity is ensured by using protatran 4-chlor-2-methylphenoxyacetate (chlorcresacin).EFFECT: using this compound enables increasing the cholesterol resistance of the vascular system involved into a developing atherosclerotic process.2 tbl Настоящее изобретение относится к медицине, а именно к терапии, и касается коррекции патологических процессов, обусловленных повышенной активностью холестеролэстеразы. Для этого применяют протатран 4-хлор-2-метилфеноксиацетат (хлоркрезацин). Применение этого соединения позволяет повышать устойчивость сосудистой системы к холестерину при развитии атеросклеротического процесса. 2 табл.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; rus
recordid cdi_epo_espacenet_RU2563831C1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title USING PROTATRAN 4-CHLOR-2-METHYLPHENOXYACETATE (CHLORCRESACIN) FOR ARREST OF CHOLESTEROLESTERASE ACTIVITY
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T19%3A20%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=RASULOV%20MAKSUD%20MUKHAMEDZHANOVICH&rft.date=2015-09-20&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ERU2563831C1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true